Global Lung Oncology Branch trial 3 (GLOB3): final results of a randomised multinational phase III study alternating oral and i.v. vinorelbine plus cisplatin versus docetaxel plus cisplatin as first-line treatment of advanced non-small-cell lung cancer

E. H Tan, J Rolski, T Grodzki, C. P Schneider, U Gatzemeier, P Zatloukal, E Aitini, G Carteni, H Riska, Y. H Tsai and R. Abratt

Annals of Oncology 20 ( 7 ): 1249 - 1256 , 2009